Real-time enrollment status for this primary immune deficiency clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05787574 |
| Recruiting Status | Recruiting |
| Condition | Primary Immune Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 39 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | October 29, 2025 (Oct 29, 2025) |
As of March 2, 2026: Clinical trial NCT05787574 is currently recruiting participants. This clinical trial study for primary immune deficiency is actively seeking new participants at 12 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05787574 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05787574 was last updated Oct 29, 2025 (October 29, 2025). HelloStudys verifies this status automatically.